~~<i id='AE97C3D2DB'><strike id='AE97C3D2DB'><tt id='AE97C3D2DB'><pre id='AE97C3D2DB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：Wikipedia 2025-09-29 18:59:27 - browse：26

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： #NeedHerScience: shining a light on gender disparities in medicine

hotspot

focus

entertainment

explore

hotspot

KobiWolf/BloombergPfizersaidTuesdaythatamuch-watchedstudyofitsantiviralPaxlovidinpatientswhohaveCovi

WSS

Why drug prescriptions should include diagnoses

5 shark bites reported on Long Island as officials deploy surveillance drones

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

The battle over the Brookhaven Landfill on Long Island

Why drug prescriptions should include diagnoses

knowledge

Wikipedia

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

EU moves toward latest gene techniques in food production to counter climate change, shortages

Walensky prepares to leave CDC — and Congress — behind

Death of patient in Alzheimer’s trial raises question of possible risks

Medical records are filled with copy

Weight bias in eating disorder treatment complicated by new weight loss drugs

Anesthesiologist group: stop taking Ozempic before surgery

China dismisses criticism of top diplomat's comments appearing to push for race

The high cost of giving birth even with insurance

New guidelines on severe brain injury complicate already difficult decisions

hotspot

CDC concerned about possible undetected monkeypox spread in U.K.

STAT's guide to the next generation of CAR

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Pentagon will tighten controls on classified information after Discord leak

Cloning humans is technically possible. It's curious no one has tried

focus

entertainment

explore

hotspot